Related Experiment Video
Updated: Aug 18, 2026

Cell Population Analyses During Skin Carcinogenesis
Published on: August 21, 2013
A role of PDGFRalpha in basal cell carcinoma proliferation
1Cancer Research Institute, and Department of Dermatology, University of California, San Francisco, CA 94115, USA. jinxie@utmb.edu
Abstract:
Activation of the hedgehog pathway, through the loss of patched (PTC) or the activation of smoothened (SMO), occurs frequently in basal cell carcinoma (BCC), the most common human cancer. However, the molecular basis of this neoplastic effect is not understood. The downstream molecule Gli1 is known to mediate the biological effect of the pathway and is itself up-regulated in all BCCs. Gli1 can drive the production of BCCs in the mouse when overexpressed in the epidermis. Here we show that Gli1 can activate platelet-derived growth factor receptor alpha (PDGFRalpha) in C3H10T(1/2) cells. Functional up-regulation of PDGFRalpha by Gli1 is accompanied by activation of the ras-ERK pathway, a pathway associated with cell proliferation. The relevance of this mechanism in vivo is supported by a high level expression of PDGFRalpha in BCCs of mice and humans. In the murine BCC cell line ASZ001, in which both copies of the PTC gene are inactivated, DNA synthesis and cell proliferation can be slowed by re-expression of PTC, which down-regulates PDGFRalpha expression, or by downstream inhibition of PDGFRalpha with neutralizing antibodies. Therefore, we conclude that increased expression of PDGFRalpha may be an important mechanism by which mutations in the hedgehog pathway cause BCCs.
Insights
Activation of the hedgehog pathway in basal cell carcinoma (BCC) drives platelet-derived growth factor receptor alpha (PDGFRalpha) expression. This PDGFRalpha up-regulation promotes cancer cell proliferation, offering a new therapeutic target for BCC.
Area of Science:
- Oncology
- Molecular Biology
- Dermatology
Background:
- Basal cell carcinoma (BCC) is the most common human cancer, frequently driven by hedgehog pathway activation.
- The precise molecular mechanisms linking hedgehog pathway activation to BCC development remain unclear.
Purpose of the Study:
- To elucidate the molecular mediators of hedgehog pathway-driven oncogenesis in BCC.
- To investigate the role of Gli1 in regulating downstream targets involved in BCC proliferation.
Main Methods:
- Investigated Gli1-mediated activation of platelet-derived growth factor receptor alpha (PDGFRalpha) in C3H10T(1/2) cells.
- Analyzed the activation of the ras-ERK pathway downstream of PDGFRalpha.
- Examined PDGFRalpha expression in murine and human BCC samples.
- Assessed the impact of Patched (PTC) re-expression and PDGFRalpha inhibition on BCC proliferation in vitro.
Main Results:
- Gli1 was shown to activate PDGFRalpha, leading to ras-ERK pathway activation and promoting cell proliferation.
- High PDGFRalpha expression was observed in both murine and human BCCs.
- Re-expression of PTC or inhibition of PDGFRalpha significantly reduced proliferation in a murine BCC cell line.
Conclusions:
- Increased PDGFRalpha expression is a key mechanism by which hedgehog pathway mutations contribute to BCC.
- Targeting PDGFRalpha represents a potential therapeutic strategy for basal cell carcinoma.
More Related Videos
08:19Evaluation of Keratinocyte Proliferation on Two- and Three-dimensional Type I Collagen Substrates
Published on: April 22, 2019
06:25Ex Vivo Culture of Circulating Tumor Cells in the Cerebral Spinal Fluid from Melanoma Patients to Study Melanoma-Associated Leptomeningeal Disease
Published on: March 29, 2024
Related Concept Videos
Negative Regulator Molecules
Inhibition of Cdk Activity
Mitogens and the Cell Cycle
Abnormal Proliferation
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Abnormal Proliferation